28 research outputs found
The neurogenic effects of exogenous neuropeptide Y: early molecular events and long-lasting effects in the hippocampus of trimethyltin-treated rats.
Modulation of endogenous neurogenesis is regarded as a promising challenge in neuroprotection. In the rat model of hippocampal neurodegeneration obtained by Trimethyltin (TMT) administration (8 mg/kg), characterised by selective pyramidal cell loss, enhanced neurogenesis, seizures and cognitive impairment, we previously demonstrated a proliferative role of exogenous neuropeptide Y (NPY), on dentate progenitors in the early phases of neurodegeneration. To investigate the functional integration of newly-born neurons, here we studied in adult rats the long-term effects of intracerebroventricular administration of NPY (2 \ub5g/2 \ub5l, 4 days after TMT-treatment), which plays an adjuvant role in neurodegeneration and epilepsy. Our results indicate that 30 days after NPY administration the number of new neurons was still higher in TMT+NPY-treated rats than in control+saline group. As a functional correlate of the integration of new neurons into the hippocampal network, long-term potentiation recorded in Dentate Gyrus (DG) in the absence of GABAA receptor blockade was higher in the TMT+NPY-treated group than in all other groups. Furthermore, qPCR analysis of Kruppel-like factor 9, a transcription factor essential for late-phase maturation of neurons in the DG, and of the cyclin-dependent kinase 5, critically involved in the maturation and dendrite extension of newly-born neurons, revealed a significant up-regulation of both genes in TMT+NPY-treated rats compared with all other groups. To explore the early molecular events activated by NPY administration, the Sonic Hedgehog (Shh) signalling pathway, which participates in the maintenance of the neurogenic hippocampal niche, was evaluated by qPCR 1, 3 and 5 days after NPY-treatment. An early significant up-regulation of Shh expression was detected in TMT+NPY-treated rats compared with all other groups, associated with a modulation of downstream genes. Our data indicate that the neurogenic effect of NPY administration during TMT-induced neurodegeneration involves early Shh pathway activation and results in a functional integration of newly-generated neurons into the local circuit
Microglial Pruning: Relevance for Synaptic Dysfunction in Multiple Sclerosis and Related Experimental Models
Microglia, besides being able to react rapidly to a wide range of environmental changes, are also involved in shaping neuronal wiring. Indeed, they actively participate in the modulation of neuronal function by regulating the elimination (or "pruning") of weaker synapses in both physiologic and pathologic processes. Mounting evidence supports their crucial role in early synaptic loss, which is emerging as a hallmark of several neurodegenerative diseases, including multiple sclerosis (MS) and its preclinical models. MS is an inflammatory, immune-mediated pathology of the white matter in which demyelinating lesions may cause secondary neuronal death. Nevertheless, primitive grey matter (GM) damage is emerging as an important contributor to patients' long-term disability, since it has been associated with early and progressive cognitive decline (CD), which seriously worsens the quality of life of MS patients. Widespread synapse loss even in the absence of demyelination, axon degeneration and neuronal death has been demonstrated in different GM structures, thus raising the possibility that synaptic dysfunction could be an early and possibly independent event in the neurodegenerative process associated with MS. This review provides an overview of microglial-dependent synapse elimination in the neuroinflammatory process that underlies MS and its experimental models
Trimethyltin-induced expression of protease-activated receptor-1 in rat microglia
Neuroinflammation is a prominent feature shared by various neurodegenerative
diseases and it is important to identify the signal pathways
that control the initiation, progression and termination of the inflammatory
reaction since a well-regulated inflammatory process is essential
for tissue homeostasis. Protease-activated receptors (PARs) are
cleaved and activated by thrombin and other extracellular proteaseswhich are released during tissue trauma and inflammation. PAR-1 is
the prototypic member of the PAR family and has been shown to be
upregulated in several brain pathologies being expressed by neurons
and glial cells. Our previous results show that PAR-1 expression is
increased in astrocytes both in vivo and in vitro after treatment with
the neurotoxic compound trimethyltin (TMT). Administration of TMT
to the rat results in loss of hippocampal neurons and an ensuing gliosis
without blood-brain barrier compromise. TMT caused pyramidal cell
damage within 3 days and a substantial loss of these neurons by 21
days post dosing. Marked microglial activation and astrogliosis are evident
over the same time period. TMT causes large increase of PAR-1
immunoreactivity in microglia by day 7 while in untreated controls this
receptor is barely detectable. In vitro data show that the administration
of the PAR-1 activating peptides (TRAP6 and TFLLR) inhibits the production
of the pro-inflammatory cytokines TNF-alpha and IL-6 in
microglial cells treated with lipopolysaccharide (LPS) while promoting
the release of the anti-inflammatory cytokine IL-10. Our results suggest
that PAR-1 may be involved in the regulation of the inflammatory
response in the brain